Skip to main content

Intuitive Surgical

Intuitive Surgical, Inc. is an American medical technology pioneer that designs, manufactures, and markets robotic-assisted surgical systems for minimally invasive procedures. The company structures its operational business activities around primary reportable technology platforms, led by the da Vinci Surgical System and the Ion endoluminal system. Its product portfolio encompasses multi-port robotic surgery consoles, wristed surgical instruments, 3D vision systems, and catheter-based diagnostic platforms. Principal revenue drivers consist of recurring sales of specialized robotic instruments and accessories, system console sales to hospital networks, and long-term service contracts. Intuitive Surgical serves global healthcare end markets including general surgery departments, urology clinics, gynecology centers, thoracic surgery units, and acute care hospitals worldwide. The corporation holds a dominant global market position as the world's leading manufacturer of robotic-assisted minimally invasive surgical systems. Headquartered in Sunnyvale, California, the company's common stock is publicly listed on the Nasdaq Global Select Market under the ticker symbol ISRG and is included in the S&P 500 index.

80 of the funds FundTelligence covers report a position in Intuitive Surgical.

Sector
Health Care
Country
United States
Funds holding it
80
Exposure themes
Surgical technology, Treatment, Women's Health, Healthcare, Robotics & Automation, Surgical Robotics, Automation & Robotics, Robotics, Technology Themes

Funds holding Intuitive Surgical

Showing the 8 largest of 80 funds holding it.

Loading...